Credence Research Logo

Home » Healthcare » Pharmaceuticals » Marknaden för bioläkemedel

Marknaden för bioläkemedel

Marknaden för bioläkemedel efter produkttyp (monoklonala antikroppar, rekombinanta proteiner, rekombinanta hormoner, vacciner, rekombinanta enzymer, cell- och genterapier, cytokiner, interferoner och interleukiner, tillväxtfaktorer, andra produkttyper); efter terapeutisk tillämpning (onkologi, inflammatoriska och infektionssjukdomar, autoimmuna sjukdomar, metabola sjukdomar, hormonella sjukdomar, kardiovaskulära sjukdomar, neurologiska sjukdomar, andra terapeutiska tillämpningar); efter läkemedelstyp (patentskyddade/varumärkesskyddade biologiska läkemedel, biosimilarer); efter region – tillväxt, andel, möjligheter och konkurrensanalys, 2025 – 2032

Report ID: 206230 | Report Format : Excel, PDF

Begär ett gratisprov

Begär gratis prov

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Begär din provrapport och börja din resa mot välgrundade beslut

Tillhandahåller den strategiska kompassen för branschledare.

cr-clients-logos
Vanliga frågor:
Vad är marknadsstorleken för biopharmaceuticals-marknaden år 2025 och prognosen för 2032?

Biopharmaceuticals-marknaden värderades till 457 158,2 miljoner USD år 2025. Marknaden förväntas nå 783 488,82 miljoner USD år 2032.

Vad är CAGR för biopharmaceuticals-marknaden under 2025–2032?

Marknaden förväntas växa med en CAGR på 8% från 2025 till 2032. Denna tillväxt återspeglar en ökad adoption inom specialterapiområden och en utvidgning av tillgången.

Vilket är det största segmentet efter produkttyp år 2025?

Monoklonala antikroppar är den största produktsegmentet. Monoklonala antikroppar stod för 35,4% av marknadsandelen år 2025.

Vilka är de viktigaste faktorerna som driver biopharmaceuticals-marknaden?

Nyckelfaktorer för tillväxt inkluderar en ökande börda av specialiserade sjukdomar, fortsatt innovation inom biologiska plattformar och en expanderande tillverkningskapacitet. Förbättrad tillgång och överkomliga priser genom biosimilarer stöder också en bredare adoption.

Vilka är de ledande företagen på biopharmaceuticals-marknaden?

Ledande företag inkluderar Pfizer Inc., AbbVie Inc., Merck & Co., Inc., F. Hoffmann-La Roche Ltd. och Novartis AG. Andra stora aktörer inkluderar Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company och Sanofi.

Vilken region leder biopharmaceuticalsmarknaden 2025?

Nordamerika leder marknaden 2025. Nordamerika stod för 43,6% av den globala intäkten 2025.

About Author

Shweta Bisht

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports

North America Over-the-Counter (OTC) Drugs Market

The North America Over-the-Counter (OTC) Drugs Market size was valued at USD 72,391.68 MN in 2021 and reached USD 93,061.46 MN in 2025. It is anticipated to reach USD 155,694.86 MN by 2032, growing at a CAGR of 6.49% during the forecast period.

North America Specialty Pharmaceuticals Market

The North America Specialty Pharmaceuticals Market size was valued at USD 67,838.21 MN in 2021 and reached USD 109,086.83 MN in 2025. It is anticipated to reach USD 260,733.67 MN by 2032, growing at a CAGR of 11.03% during the forecast period.

Europe Prescription Drugs Market

The Europe Prescription Drugs Market size was valued at USD 294,866.12 MN in 2021 and reached USD 365,960.68 MN in 2025. It is anticipated to reach USD 553,623.53 MN by 2032, growing at a CAGR of 5.13% during the forecast period.

Cell Therapy Consumables Market

Cell therapy consumables Market was valued at USD 3439 million in 2024 and is anticipated to reach USD 7533.31 million by 2032, growing at a CAGR of 10.3% during the forecast period.

Africa Orphan Drugs Market

The Africa Orphan Drugs Market size was valued at USD 792.75 MN in 2021 and reached USD 1,258.16 MN in 2025. It is anticipated to reach USD 2,826.51 MN by 2032, growing at a CAGR of 6.30% during the forecast period.

Africa Biosimilars Market

The Africa Biosimilars Market size was valued at USD 126.63 MN in 2021 and reached USD 200.98 MN in 2025. It is anticipated to reach USD 451.50 MN by 2032, growing at a CAGR of 7.80% during the forecast period.

Europe Dermatology Drugs Market

The Europe Dermatology Drugs Market size was valued at USD 8,384.62 MN in 2021 and reached USD 10,909.79 MN in 2025. It is anticipated to reach USD 17,933.36 MN by 2032, growing at a CAGR of 6.18% during the forecast period.

North America Pain Management Drugs Market

The North America Pain Management Drugs Market size was valued at USD 11,968.20 MN in 2021 and reached USD 14,314.26 MN in 2025. It is anticipated to reach USD 18,345.24 MN by 2032, growing at a CAGR of 2.85% during the forecast period.

North America Respiratory Drugs Market

The North America Respiratory Drugs Market size was valued at USD 4,603.33 MN in 2021 and reached USD 5,912.29 MN in 2025. It is anticipated to reach USD 8,990.65 MN by 2032, growing at a CAGR of 5.07% during the forecast period.

North America CNS Drugs Market

The North America CNS Drugs Market size was valued at USD 29,971.81 MN in 2021 and reached USD 39,376.62 MN in 2025. It is anticipated to reach USD 64,694.22 MN by 2032, growing at a CAGR of 6.13% during the forecast period.

Asia Pacific Gastrointestinal Drugs Market

The Asia Pacific Gastrointestinal Drugs Market size was valued at USD 14,076.07 MN in 2021 and reached USD 18,379.23 MN in 2025. It is anticipated to reach USD 27,675.57 MN by 2032, growing at a CAGR of 4.86% during the forecast period.

North America Immunology Drugs Market

The North America Immunology Drugs Market size was valued at USD 23,174.02 MN in 2021 and reached USD 34,194.85 MN in 2025. It is anticipated to reach USD 70,564.69 MN by 2032, growing at a CAGR of 9.11% during the forecast period.

Licensalternativ

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
$7999

Report delivery within 24 to 48 hours

Snabbkontakt

Europe

+44 7453 598 606

North America

+1 6282 627 656

Email

[email protected]

Begär ett gratisprov

Smallform of Sample request

What people say?

User Review

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materialforskare
(privacy requested)

User Review

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Ledningsassistent, Bekaert

Betrodd av

cr-clients-logos

Request Sample